Michela Piredda, Chiara Mastroianni, Anna Marchetti, Marco Sguanci, Riccardo Farinella, Martina Natale, Diana Giannarelli, Eleonora Monaco, Matteo Martinato, Grazia Armento, Giuseppe Casale, Maria Grazia De Marinis
{"title":"基于蜂胶的姑息治疗口腔健康方案:来自II期试验的结果","authors":"Michela Piredda, Chiara Mastroianni, Anna Marchetti, Marco Sguanci, Riccardo Farinella, Martina Natale, Diana Giannarelli, Eleonora Monaco, Matteo Martinato, Grazia Armento, Giuseppe Casale, Maria Grazia De Marinis","doi":"10.1089/jpm.2024.0290","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Oral disorders (ODs) in palliative care (PC) are highly prevalent and significantly impact patients' quality of life (QoL). Nevertheless, evidence-based management recommendations are lacking. Several natural products are safe, well-accepted, and effective for mucosal conditions. <b><i>Objective:</i></b> The study aimed to evaluate the efficacy of a propolis-based product combined with basic oral hygiene in preventing and treating ODs. <b><i>Design:</i></b> A prospective, open-label, single-center phase II study was performed. Adult patients in PC with cancer or noncancer diagnoses, who were conscious, able to swallow, with a life expectancy of more than one week, were recruited. <b><i>Results:</i></b> ODs' improvement or maintenance of oral health was observed in 89.6% of cases. Severity of ODs significantly decreased (<i>p</i> < 0.001), along with reductions in oropharyngeal pain (<i>p</i> = 0.002) and dysgeusia (<i>p</i> < 0.001). Meal comfort, completion, and QoL improved; acceptability was excellent. <b><i>Conclusions:</i></b> The protocol was safe, well-accepted, and effective for ODs in adult patients in PC. <b><i>Study registration:</i></b> The study protocol was prospectively registered at ClinicalTrials.gov: NCT04911335.</p>","PeriodicalId":16656,"journal":{"name":"Journal of palliative medicine","volume":" ","pages":"243-250"},"PeriodicalIF":2.2000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Propolis-Based Protocol for Oral Health in Palliative Care: Results from a Phase II Trial.\",\"authors\":\"Michela Piredda, Chiara Mastroianni, Anna Marchetti, Marco Sguanci, Riccardo Farinella, Martina Natale, Diana Giannarelli, Eleonora Monaco, Matteo Martinato, Grazia Armento, Giuseppe Casale, Maria Grazia De Marinis\",\"doi\":\"10.1089/jpm.2024.0290\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background:</i></b> Oral disorders (ODs) in palliative care (PC) are highly prevalent and significantly impact patients' quality of life (QoL). Nevertheless, evidence-based management recommendations are lacking. Several natural products are safe, well-accepted, and effective for mucosal conditions. <b><i>Objective:</i></b> The study aimed to evaluate the efficacy of a propolis-based product combined with basic oral hygiene in preventing and treating ODs. <b><i>Design:</i></b> A prospective, open-label, single-center phase II study was performed. Adult patients in PC with cancer or noncancer diagnoses, who were conscious, able to swallow, with a life expectancy of more than one week, were recruited. <b><i>Results:</i></b> ODs' improvement or maintenance of oral health was observed in 89.6% of cases. Severity of ODs significantly decreased (<i>p</i> < 0.001), along with reductions in oropharyngeal pain (<i>p</i> = 0.002) and dysgeusia (<i>p</i> < 0.001). Meal comfort, completion, and QoL improved; acceptability was excellent. <b><i>Conclusions:</i></b> The protocol was safe, well-accepted, and effective for ODs in adult patients in PC. <b><i>Study registration:</i></b> The study protocol was prospectively registered at ClinicalTrials.gov: NCT04911335.</p>\",\"PeriodicalId\":16656,\"journal\":{\"name\":\"Journal of palliative medicine\",\"volume\":\" \",\"pages\":\"243-250\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of palliative medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/jpm.2024.0290\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of palliative medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/jpm.2024.0290","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
A Propolis-Based Protocol for Oral Health in Palliative Care: Results from a Phase II Trial.
Background: Oral disorders (ODs) in palliative care (PC) are highly prevalent and significantly impact patients' quality of life (QoL). Nevertheless, evidence-based management recommendations are lacking. Several natural products are safe, well-accepted, and effective for mucosal conditions. Objective: The study aimed to evaluate the efficacy of a propolis-based product combined with basic oral hygiene in preventing and treating ODs. Design: A prospective, open-label, single-center phase II study was performed. Adult patients in PC with cancer or noncancer diagnoses, who were conscious, able to swallow, with a life expectancy of more than one week, were recruited. Results: ODs' improvement or maintenance of oral health was observed in 89.6% of cases. Severity of ODs significantly decreased (p < 0.001), along with reductions in oropharyngeal pain (p = 0.002) and dysgeusia (p < 0.001). Meal comfort, completion, and QoL improved; acceptability was excellent. Conclusions: The protocol was safe, well-accepted, and effective for ODs in adult patients in PC. Study registration: The study protocol was prospectively registered at ClinicalTrials.gov: NCT04911335.
期刊介绍:
Journal of Palliative Medicine is the premier peer-reviewed journal covering medical, psychosocial, policy, and legal issues in end-of-life care and relief of suffering for patients with intractable pain. The Journal presents essential information for professionals in hospice/palliative medicine, focusing on improving quality of life for patients and their families, and the latest developments in drug and non-drug treatments.
The companion biweekly eNewsletter, Briefings in Palliative Medicine, delivers the latest breaking news and information to keep clinicians and health care providers continuously updated.